Randomized Clinical Study for Pharmacokinetics and Pharmacodynamics Assessment of Drug Eritromax, Marketed by the Blausiegel Laboratory, Compared to Drug Eprex, Produced by Janssen-Cilag Laboratory, in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 27 Jun 2019
Price : $35 *
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Anaemia
- Focus Pharmacodynamics; Pharmacokinetics
- 27 Jun 2019 Last checked against ClinicalTrials.gov record.
- 04 Jul 2018 New trial record